Tokyo Tape
Sign in
← MedPeer

Quarterly report · Q2

6095.TEDINET S100TEBI
Period2023-10-01 → 2024-03-31
Filed2024-05-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
MetricValuePeriodScopeSource row
Revenue¥7.9bn2023-10-01 → 2024-03-31Cons.Net sales
Revenue¥14.5bn2022-10-01 → 2023-09-30Cons.Net sales (5-year summary)
Revenue¥7.1bn2022-10-01 → 2023-03-31Cons.Net sales
Operating income¥836m2023-10-01 → 2024-03-31Cons.Operating income
Operating income¥717m2022-10-01 → 2023-03-31Cons.Operating income
Ordinary income¥831m2023-10-01 → 2024-03-31Cons.Ordinary income
Ordinary income¥1.2bn2022-10-01 → 2023-09-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥735m2022-10-01 → 2023-03-31Cons.Ordinary income
Profit before tax¥550m2023-10-01 → 2024-03-31Cons.Income before income taxes
Profit before tax¥735m2022-10-01 → 2023-03-31Cons.Income before income taxes
Net income (owners)¥199m2023-10-01 → 2024-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥618m2022-10-01 → 2023-09-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥380m2022-10-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income¥213m2023-10-01 → 2024-03-31Cons.Profit loss
Net income¥391m2022-10-01 → 2023-03-31Cons.Profit loss
Total assets¥14.9bnat 2024-03-31Cons.Assets
Total assets¥15.2bnat 2023-09-30Cons.Assets
Total assets¥14.5bnat 2023-03-31Cons.Total assets (5-year summary)
Total liabilities¥6.2bnat 2024-03-31Cons.Liabilities
Total liabilities¥6.6bnat 2023-09-30Cons.Liabilities
Net assets / equity¥8.7bnat 2024-03-31Cons.Net assets
Net assets / equity¥8.6bnat 2023-09-30Cons.Net assets
Net assets / equity¥8.6bnat 2023-03-31Cons.Net assets (5-year summary)
Cash and deposits¥5.8bnat 2024-03-31Cons.Cash and deposits
Cash and deposits¥5.4bnat 2023-09-30Cons.Cash and deposits
Cash & equivalents¥5.8bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥5.4bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥5.7bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥6.1bnat 2022-09-30dCons.Cash and cash equivalents
Operating cash flow¥807m2023-10-01 → 2024-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥600m2022-10-01 → 2023-09-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥122m2022-10-01 → 2023-03-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥47m2023-10-01 → 2024-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥5.0bn2022-10-01 → 2023-09-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥4.8bn2022-10-01 → 2023-03-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥378m2023-10-01 → 2024-03-31Cons.Net cash provided by used in financing activities
Financing cash flow¥3.7bn2022-10-01 → 2023-09-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥4.2bn2022-10-01 → 2023-03-31Cons.Net cash provided by used in financing activities
EPS (basic)¥9.182023-10-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-4.162024-01-01 → 2024-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥28.332022-10-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥17.422022-10-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥5.032023-01-01 → 2023-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥27.992022-10-01 → 2023-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥17.052022-10-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
Equity ratio56.5%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio54.7%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio57.6%at 2023-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 37
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-10-01 → 2024-03-31−¥434,000
Reconciling Itemsreconcilingrevenue intersegment2023-10-01 → 2024-03-31−¥434,000
Reconciling Itemsreconcilingsegment profit2023-10-01 → 2024-03-31−¥685m
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue2023-10-01 → 2024-03-31¥6.4bn
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue external2023-10-01 → 2024-03-31¥6.4bn
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue intersegment2023-10-01 → 2024-03-31¥15,000
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentsegment profit2023-10-01 → 2024-03-31¥1.5bn
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue2023-10-01 → 2024-03-31¥234m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue external2023-10-01 → 2024-03-31¥234m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentsegment profit2023-10-01 → 2024-03-31−¥131m
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue2023-10-01 → 2024-03-31¥1.2bn
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue external2023-10-01 → 2024-03-31¥1.2bn
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue intersegment2023-10-01 → 2024-03-31¥419,000
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentsegment profit2023-10-01 → 2024-03-31¥153m
—segment totalrevenue2023-10-01 → 2024-03-31¥7.9bn
—segment totalrevenue external2023-10-01 → 2024-03-31¥7.9bn
—segment totalrevenue intersegment2023-10-01 → 2024-03-31¥434,000
—segment totalsegment profit2023-10-01 → 2024-03-31¥1.5bn
Reconciling Itemsreconcilingrevenue2022-10-01 → 2023-03-31−¥5m
Reconciling Itemsreconcilingrevenue intersegment2022-10-01 → 2023-03-31−¥5m
Reconciling Itemsreconcilingsegment profit2022-10-01 → 2023-03-31−¥657m
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue2022-10-01 → 2023-03-31¥5.7bn
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue external2022-10-01 → 2023-03-31¥5.7bn
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue intersegment2022-10-01 → 2023-03-31¥2m
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentsegment profit2022-10-01 → 2023-03-31¥1.3bn
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue2022-10-01 → 2023-03-31¥243m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue external2022-10-01 → 2023-03-31¥240m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue intersegment2022-10-01 → 2023-03-31¥3m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentsegment profit2022-10-01 → 2023-03-31−¥40m
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue2022-10-01 → 2023-03-31¥1.2bn
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue external2022-10-01 → 2023-03-31¥1.2bn
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue intersegment2022-10-01 → 2023-03-31¥300,000
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentsegment profit2022-10-01 → 2023-03-31¥94m
—segment totalrevenue2022-10-01 → 2023-03-31¥7.1bn
—segment totalrevenue external2022-10-01 → 2023-03-31¥7.1bn
—segment totalrevenue intersegment2022-10-01 → 2023-03-31¥5m
—segment totalsegment profit2022-10-01 → 2023-03-31¥1.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 519
ItemContextValueUnit
Provision for point card certificates clPrior1YearInstant187425000JPY
Provision for point card certificates clCurrentQuarterInstant109765000JPY
Contract liabilitiesPrior1YearInstant79814000JPY
Contract liabilitiesCurrentQuarterInstant101808000JPY
Other clPrior1YearInstant263571000JPY
Other clCurrentQuarterInstant397741000JPY
Current liabilitiesPrior1YearInstant2455070000JPY
Current liabilitiesCurrentQuarterInstant2379368000JPY
Long term loans payablePrior1YearInstant3186757000JPY
Long term loans payableCurrentQuarterInstant2921332000JPY
Asset retirement obligations nclPrior1YearInstant87801000JPY
Asset retirement obligations nclCurrentQuarterInstant61657000JPY
Deferred tax liabilitiesPrior1YearInstant784387000JPY
Deferred tax liabilitiesCurrentQuarterInstant747202000JPY
Net defined benefit liabilityPrior1YearInstant59485000JPY
Net defined benefit liabilityCurrentQuarterInstant64688000JPY
Other nclPrior1YearInstant1365000JPY
Other nclCurrentQuarterInstant457000JPY
Noncurrent liabilitiesPrior1YearInstant4119796000JPY
Noncurrent liabilitiesCurrentQuarterInstant3795337000JPY
LiabilitiesPrior1YearInstant6574867000JPY
LiabilitiesCurrentQuarterInstant6174706000JPY
Capital stockPrior1YearInstant2244624000JPY
Capital stockCurrentQuarterInstant2256559000JPY
Capital surplusPrior1YearInstant2500036000JPY
Capital surplusCurrentQuarterInstant2511971000JPY
Retained earningsPrior1YearInstant3854651000JPY
Retained earningsCurrentQuarterInstant3956334000JPY
Treasury stockPrior1YearInstant-300745000JPY
Treasury stockCurrentQuarterInstant-300745000JPY
Shareholders equityPrior1YearInstant8298567000JPY
Shareholders equityCurrentQuarterInstant8424119000JPY
Valuation difference on available for sale securitiesPrior1YearInstant-12736000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant-13115000JPY
Remeasurements of defined benefit plansPrior1YearInstant1136000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant713000JPY
Valuation and translation adjustmentsPrior1YearInstant-11599000JPY
Valuation and translation adjustmentsCurrentQuarterInstant-12402000JPY
Subscription rights to sharesPrior1YearInstant8778000JPY
Subscription rights to sharesCurrentQuarterInstant8778000JPY
Non controlling interestsPrior1YearInstant291549000JPY
Non controlling interestsCurrentQuarterInstant305726000JPY
Net assetsPrior1YearInstant8587296000JPY
Net assetsCurrentQuarterInstant8726222000JPY
Liabilities and net assetsPrior1YearInstant15162163000JPY
Liabilities and net assetsCurrentQuarterInstant14900928000JPY
Net salesPrior1YTDDuration7129040000JPY
Net salesCurrentYTDDuration7850221000JPY
Cost of salesPrior1YTDDuration3603351000JPY
Cost of salesCurrentYTDDuration4196668000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-09-30pass
balance sheet identityconsolidated 2024-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-10-01/2024-03-31pass
statement vs summary · operating cash flowconsolidated 2022-10-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2023-10-01/2024-03-31pass
statement vs summary · revenueconsolidated 2022-10-01/2023-03-31pass
statement vs summary · revenueconsolidated 2023-10-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass